These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35203756)

  • 41. Fosfomycin in severe infections due to genetically distinct pan-drug-resistant Gram-negative microorganisms: synergy with meropenem.
    Perdigão Neto LV; Oliveira MS; Martins RCR; Marchi AP; Gaudereto JJ; da Costa LATJ; de Lima LFA; Takeda CFV; Costa SF; Levin AS
    J Antimicrob Chemother; 2019 Jan; 74(1):177-181. PubMed ID: 30376073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
    Ontong JC; Ozioma NF; Voravuthikunchai SP; Chusri S
    PLoS One; 2021; 16(1):e0244673. PubMed ID: 33406110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae.
    Fergadaki S; Renieris G; Machairas N; Sabracos L; Droggiti DI; Misiakos E; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2021 Sep; 58(3):106384. PubMed ID: 34161789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran.
    Farhadi M; Ahanjan M; Goli HR; Haghshenas MR; Gholami M
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):70. PubMed ID: 34583687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic characterisation of a colistin-resistant Klebsiella pneumoniae ST11 strain co-producing KPC-2, FloR, CTX-M-55, SHV-12, FosA and RmtB causing a lethal infection.
    Xiaoliang W; Huiming H; Chunlei C; Beiwen Z
    J Glob Antimicrob Resist; 2019 Dec; 19():78-80. PubMed ID: 31493525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [UhpT
    DA R; Zhou Y; Cheng Y; Lv J; Han B
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1110-1115. PubMed ID: 37488793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time-kill synergy tests of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Yim H; Woo H; Song W; Park MJ; Kim HS; Lee KM; Hur J; Park MS
    Ann Clin Lab Sci; 2011; 41(1):39-43. PubMed ID: 21325253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic Characterisation of Colistin Resistant
    Singh S; Pathak A; Rahman M; Singh A; Nag S; Sahu C; Prasad KN
    Front Cell Infect Microbiol; 2021; 11():666030. PubMed ID: 34235092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of carbapenem resistance mechanisms in Klebsiella pneumoniae and in vitro synergy of the colistin-meropenem combination.
    Krishnappa LG; Marie MA; Al Sheikh YA
    J Chemother; 2015 Oct; 27(5):277-82. PubMed ID: 24871673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
    Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Galani I; Nafplioti K; Chatzikonstantinou M; Souli M
    J Med Microbiol; 2018 May; 67(5):662-668. PubMed ID: 29561258
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
    Wang F; Zhou Q; Yang X; Bai Y; Cui J
    PLoS One; 2021; 16(10):e0258426. PubMed ID: 34648556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
    Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
    J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant
    Abdul-Mutakabbir JC; Yim J; Nguyen L; Maassen PT; Stamper K; Shiekh Z; Kebriaei R; Shields RK; Castanheira M; Kaye KS; Rybak MJ
    Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356801
    [No Abstract]   [Full Text] [Related]  

  • 57. Whole-Genome Sequencing of Gram-Negative Bacteria Isolated From Bovine Mastitis and Raw Milk: The First Emergence of Colistin
    Tartor YH; Abd El-Aziz NK; Gharieb RMA; El Damaty HM; Enany S; Soliman EA; Abdellatif SS; Attia ASA; Bahnass MM; El-Shazly YA; Elbediwi M; Ramadan H
    Front Microbiol; 2021; 12():770813. PubMed ID: 34956131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of the first New Delhi metallo-ß-lactamase-1 (NDM-1)-producing and colistin-resistant Klebsiella pneumoniae sequence type ST15 from a digestive carrier in Albania, May 2018.
    Tafaj S; Gona F; Kapisyzi P; Cani A; Hatibi A; Bino S; Fico A; Koraqi A; Kasmi G; Cirillo D
    J Glob Antimicrob Resist; 2019 Jun; 17():142-144. PubMed ID: 30557684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.
    Simner PJ; Antar AAR; Hao S; Gurtowski J; Tamma PD; Rock C; Opene BNA; Tekle T; Carroll KC; Schatz MC; Timp W
    J Antimicrob Chemother; 2018 Jul; 73(7):1796-1803. PubMed ID: 29648629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro interactions of combinations of colistin with meropenem, rifampicin and tigecycline in colistin-resistant, biofilm-forming Klebsiella pneumoniae.
    Müderris T; Dursun Manyaslı G; Kaya S; Gül Yurtsever S
    Diagn Microbiol Infect Dis; 2024 Oct; 110(2):116408. PubMed ID: 39079190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.